<DOC>
	<DOCNO>NCT00357279</DOCNO>
	<brief_summary>The purpose trial evaluate safety effectiveness one dose strength denufosol compare placebo patient mild CF lung disease .</brief_summary>
	<brief_title>Study Denufosol Inhalation Solution Patients With Mild Cystic Fibrosis Lung Disease</brief_title>
	<detailed_description />
	<mesh_term>Fibrosis</mesh_term>
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Cystic Fibrosis</mesh_term>
	<mesh_term>Pulmonary Fibrosis</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<criteria>Have confirm diagnosis cystic fibrosis Have FEV1 great equal 75 % predict normal age , gender , height Be able reproducibly perform spirometry maneuver Be clinically stable least 4 week prior screen Have abnormal renal liver function Have chest xray screen suggest clinically significant active pulmonary disease Be colonize Burkholderia cepacia Have lung transplant</criteria>
	<gender>All</gender>
	<minimum_age>5 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2015</verification_date>
</DOC>